Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease

Image 2-Oxbryta (voxelotor)
RBCs become hard, deoxygenated and crescent- or C-shaped in patients with haemoglobin polymerisation. Credit: Global Blood Therapeutics, Inc.